Benzinga | Oct 28, 2021 07:37AM EDT

Aldeyra Therapeutics Q3 EPS $(0.27) Misses $(0.26) Estimate

Aldeyra Therapeutics (NASDAQ:ALDX) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.26) by 3.85 percent. This is a 17.39 percent decrease over losses of $(0.23) per share from the same period last year.